Bassi Mehak, Mohapatra Sonmoon, Sharma Parth, Korman Andrew, Pitchumoni C S, Broder Arkady
Division of Internal Medicine, Saint Peter's University Hospital/Rutgers Robert Wood Johnson School of Medicine, New Brunswick, USA.
Division of Gastroenterology and Hepatology, Saint Peter's University Hospital/Rutgers Robert Wood Johnson School of Medicine, New Brunswick, USA.
Cureus. 2021 Aug 8;13(8):e16992. doi: 10.7759/cureus.16992. eCollection 2021 Aug.
Enteropathy-associated T-cell lymphoma (EATL) is a tumor of intraepithelial T-lymphocytes arising in the small intestine. Based on the genetic profile, immunohistochemistry, and histology, EATL is divided into two subtypes. EATL type I occurs in individuals with celiac disease (CD) while EATL type II is a sporadic form that occurs in individuals without CD. Intensive chemotherapy and surgery are the mainstay treatment. However, despite the currently available treatment options, the five-year survival rate is only 9%. EATL presents as abdominal pain, nausea, or slow gastrointestinal bleeding. Severe bleeding leading to hemodynamic instability is rarely known in EATL. Therefore, we present a unique case of EATL who presented with acute and severe gastrointestinal bleeding with no prior history of CD.
肠病相关T细胞淋巴瘤(EATL)是一种起源于小肠上皮内T淋巴细胞的肿瘤。根据基因谱、免疫组织化学和组织学,EATL分为两个亚型。I型EATL发生于患有乳糜泻(CD)的个体,而II型EATL是一种散发性形式,发生于无CD的个体。强化化疗和手术是主要的治疗方法。然而,尽管有目前可用的治疗选择,五年生存率仅为9%。EATL表现为腹痛、恶心或胃肠道缓慢出血。EATL很少出现导致血流动力学不稳定的严重出血。因此,我们报告了一例独特的EATL病例,该患者出现急性和严重胃肠道出血,既往无CD病史。